March 5, 2020
Koch Institute for Integrative Cancer Research at MIT,
Formerly Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate off-the-record collaboration.
We’re leading influence through renowned leadership made of diverse voices. This dynamic group brings a wealth of knowledge and industry insights to the forefront.
The time is now to lead. Inspire. And enrich our efforts to better serve your needs. While upholding the legacy of our unique inception “founded by CEOs for CEOs,” Boston Biotech Conferences is moving forward with exciting new developments. Our new name, LeadingBiotech, reflects our mission to re-energize collaboration and infuse fresh ideas to better shape the future of biotech.
Our CEO event series is evolving to offer an even better experience for senior-level leaders to inform business strategies and set industry agendas. LeadingBiotech meetings will facilitate an inner-circle of peers with more interacting and less conferencing. It’s about sharing ideas. Comparing experiences. And speaking candidly in “off-the-record” dialogue. Our speakers are your peers. All attendees are experts.
WHAT TO EXPECT AT CANCER ADVANCE?
We’ve listened to the needs of the community, and we intend to deliver a more valuable experience through:
✓ New engagement re-energized by the most relevant topics and trends
✓ New simplified formats which allow for more in-depth discussions among contributors
✓ New pricing models to ensure the value delivered is worth every penny spent